Comparative Profiles of the WATCHMAN™ and Amplatzer™ Cardiac Plug/Amplatzer™ Amulet™ Devices for Left Atrial Appendage Closure in Non-valvular Atrial Fibrillation: A Comprehensive Systematic Review and Meta-analysis.

Q3 Medicine Journal of Innovations in Cardiac Rhythm Management Pub Date : 2024-06-15 eCollection Date: 2024-06-01 DOI:10.19102/icrm.2024.15061
Fnu Raja, Khimya Rani, Sunny Kumar, Fnu Someshwar, Muhammad Ahsan Naseer Khan, Fnu Abubakar, Dhvani Bhatt, Deepak Jung Subedi, Sujeet Shadmani, Fatima Tuz Zahra Abdullah
{"title":"Comparative Profiles of the WATCHMAN™ and Amplatzer™ Cardiac Plug/Amplatzer™ Amulet™ Devices for Left Atrial Appendage Closure in Non-valvular Atrial Fibrillation: A Comprehensive Systematic Review and Meta-analysis.","authors":"Fnu Raja, Khimya Rani, Sunny Kumar, Fnu Someshwar, Muhammad Ahsan Naseer Khan, Fnu Abubakar, Dhvani Bhatt, Deepak Jung Subedi, Sujeet Shadmani, Fatima Tuz Zahra Abdullah","doi":"10.19102/icrm.2024.15061","DOIUrl":null,"url":null,"abstract":"<p><p>Atrial fibrillation (AF) is a prevalent cardiac arrhythmia marked by irregular and frequent tachycardic rhythms in the atria, affecting 1%-2% of the general population. The WATCHMAN™ device from Boston Scientific (Marlborough, MA, USA) and the Amplatzer™ Amulet™ device from Abbott (Chicago, IL, USA) are two devices used globally for left atrial appendage closure (LAAC) in non-valvular AF. A systematic search was conducted in PubMed, the Cochrane Library, and Elsevier's ScienceDirect literature databases to identify studies comparing the WATCHMAN™ procedure with Amulet™ device implantation for LAAC in patients with AF. The analyses were conducted using the random-effects model. A total of 20 studies were identified, with 18 falling into the category of observational studies and 2 being randomized controlled trials. A total of 6310 participants were included in this meta-analysis, with 3198 individuals (50.68%) assigned to the WATCHMAN™ procedure group and 3112 individuals (49.32%) allocated to the Amplatzer™ Cardiac Plug (ACP) group. The analysis revealed a higher risk of stroke associated with the WATCHMAN™ technique (relative risk [RR], 1.14), albeit without statistical significance. Conversely, the WATCHMAN™ approach led to a significantly lower risk of cardiac death (RR, 0.44; <i>P</i> = .04). Notably, the risks of all-cause mortality (RR, 0.89; 95% confidence interval [CI], 0.73-1.08; <i>I</i> <sup>2</sup> = 0%; <i>P</i> = .25) and major bleeding (RR, 0.93; 95% CI, 0.65-1.33; <i>I</i> <sup>2</sup> = 31%; <i>P</i> = .70) were clinically reduced with the WATCHMAN™ procedure, although statistical significance was not achieved. Compared to Amulet™ device implantation, WATCHMAN™ device implantation decreased the risk of cardiac mortality, while the risks of stroke, systemic embolism, all-cause mortality, and major bleeding were not statistically significant.</p>","PeriodicalId":36299,"journal":{"name":"Journal of Innovations in Cardiac Rhythm Management","volume":"15 6","pages":"5917-5929"},"PeriodicalIF":0.0000,"publicationDate":"2024-06-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11210678/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Innovations in Cardiac Rhythm Management","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.19102/icrm.2024.15061","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/6/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Atrial fibrillation (AF) is a prevalent cardiac arrhythmia marked by irregular and frequent tachycardic rhythms in the atria, affecting 1%-2% of the general population. The WATCHMAN™ device from Boston Scientific (Marlborough, MA, USA) and the Amplatzer™ Amulet™ device from Abbott (Chicago, IL, USA) are two devices used globally for left atrial appendage closure (LAAC) in non-valvular AF. A systematic search was conducted in PubMed, the Cochrane Library, and Elsevier's ScienceDirect literature databases to identify studies comparing the WATCHMAN™ procedure with Amulet™ device implantation for LAAC in patients with AF. The analyses were conducted using the random-effects model. A total of 20 studies were identified, with 18 falling into the category of observational studies and 2 being randomized controlled trials. A total of 6310 participants were included in this meta-analysis, with 3198 individuals (50.68%) assigned to the WATCHMAN™ procedure group and 3112 individuals (49.32%) allocated to the Amplatzer™ Cardiac Plug (ACP) group. The analysis revealed a higher risk of stroke associated with the WATCHMAN™ technique (relative risk [RR], 1.14), albeit without statistical significance. Conversely, the WATCHMAN™ approach led to a significantly lower risk of cardiac death (RR, 0.44; P = .04). Notably, the risks of all-cause mortality (RR, 0.89; 95% confidence interval [CI], 0.73-1.08; I 2 = 0%; P = .25) and major bleeding (RR, 0.93; 95% CI, 0.65-1.33; I 2 = 31%; P = .70) were clinically reduced with the WATCHMAN™ procedure, although statistical significance was not achieved. Compared to Amulet™ device implantation, WATCHMAN™ device implantation decreased the risk of cardiac mortality, while the risks of stroke, systemic embolism, all-cause mortality, and major bleeding were not statistically significant.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
WATCHMAN™ 和 Amplatzer™ 心塞/Amplatzer™ Amulet™ 装置用于非瓣膜性心房颤动左心房阑尾封闭的比较概况:全面系统回顾和元分析》。
心房颤动(房颤)是一种常见的心律失常,其特征是心房出现不规则和频繁的心动过速节律,发病率占总人口的 1%-2%。波士顿科学公司(美国马萨诸塞州马尔堡市)的 WATCHMAN™ 装置和雅培公司(美国伊利诺斯州芝加哥市)的 Amplatzer™ Amulet™ 装置是全球用于非瓣膜性房颤的左心房阑尾关闭术 (LAAC) 的两种装置。我们在 PubMed、Cochrane Library 和 Elsevier's ScienceDirect 文献数据库中进行了系统性检索,以确定在房颤患者中比较 WATCHMAN™ 手术和 Amulet™ 装置植入术用于 LAAC 的研究。分析采用随机效应模型进行。共确定了 20 项研究,其中 18 项属于观察性研究,2 项属于随机对照试验。本次荟萃分析共纳入 6310 名参与者,其中 3198 人(50.68%)被分配到 WATCHMAN™ 手术组,3112 人(49.32%)被分配到 Amplatzer™ 心脏置管术 (ACP) 组。分析表明,WATCHMAN™ 技术的中风风险较高(相对风险 [RR],1.14),但无统计学意义。相反,WATCHMAN™ 方法导致心脏死亡的风险明显降低(RR,0.44;P = .04)。值得注意的是,WATCHMAN™ 手术降低了全因死亡风险(RR,0.89;95% 置信区间[CI],0.73-1.08;I 2 = 0%;P = .25)和大出血风险(RR,0.93;95% 置信区间[CI],0.65-1.33;I 2 = 31%;P = .70),尽管没有统计学意义。与 Amulet™ 装置植入术相比,WATCHMAN™ 装置植入术降低了心脏死亡风险,而中风、全身性栓塞、全因死亡和大出血的风险没有统计学意义。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of Innovations in Cardiac Rhythm Management
Journal of Innovations in Cardiac Rhythm Management Medicine-Cardiology and Cardiovascular Medicine
CiteScore
1.50
自引率
0.00%
发文量
70
期刊最新文献
2024 Literature Review of Postoperative Atrial Fibrillation: A Surgeon's Perspective. A Year in Review: Atrial Fibrillation 2024. Comparison of Electrocardiogram Characteristics of Two Commercially Available Implantable Loop Monitors: Impact of These Characteristics in the Correct Adjudication of Recorded Events and Minimized Undersensing and Oversensing of Events. Conduction System Pacing: Where Are We in 2025? Late Onset of Left Atrial Appendage Thrombus Under Oral Anticoagulation in a Patient with a History of Left Atrial Appendage Isolation Using Cryoballoon.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1